IgM are glycoproteins secreted by plasma cells as (µ2L2) 5 +J or (µ2L2) 6 polymers. In most species, µ-and J-chains bear five and one N-glycans, respectively. Here we compare the terminal glycosylation patterns of 4-hydroxy-3-nitrophenylacetyl (NP)-specific IgM secreted by transfectants of the J558L mouse myeloma deficient in the α2,6 sialyltransferase [α2,6ST(N)] or by a hybridoma expressing this enzyme (B1.8 cells). The absence of α2,6-sialylation results in an increased addition of α1,3-galactosyl residues to µ-and J-chain N-glycans. Since α1,3-galactosyltransferase (α1,3Gal-T) is similarly expressed in the two cell lines, these results indicate that a competition reaction occurs in vivo between α2,6ST(N) and α1,3Gal-T. In the α2,6ST(N) deficient transfectants, µ-chains lacking the C-subterminal Cys575 residue, which are secreted mainly in the form of µ2L2 monomers, are more efficiently capped by α1,3-galactosyl residues, confirming that polymerization significantly reduces the accessibility of µ-chain glycans to the Golgi processing enzymes involved in the biogenesis of antennary sugars. Functional assays indicate that IgM sialylation affects antigen-binding and complement-dependent hemolysis of haptenated red blood cells.
Introduction
Immunoglobulin M (IgM) are secreted both as pentamers or hexamers, but only the former contain one J-chain which is covalently linked to the tailpiece µ-chain cysteine (Cys575) (Della Corte and Parkhouse, 1973; Randall et al., 1992) . Murine IgM, similarly to their human counterparts, are N-glycosylated in µ-and J-chains. While the latter carries only one N-glycan (Mole et al., 1977) , murine µ-chains are glycosylated at Asn171, Asn332, Asn364, Asn402, and Asn563: this pattern is quite conserved in mammalians (Putnam et al., 1973; Kehry et al., 1979) . The site specific analysis of murine µ-chains consistently indicates that glycans at Asn171, Asn332, Asn364, Asn402 are of complex-and hybrid-type, whereas Asn563 bears mostly highmannose chains (Brenckle and Kornfeld, 1980; Anderson et al., 1985; Monica et al., 1995) . The Asn563 site was also found partially unoccupied and carrying in minor amount complex-type glycans (Anderson et al., 1983; Monica et al., 1995) . Owing to mutations or pharmacological treatments of cells, murine IgM can be secreted as µ2L2 "monomers" or µL hemimers and become resistant to endoglycosidase-H (Davis et al., 1989; Cals et al., 1996) . These findings indicate that oligomerization, an event that takes place in the endoplasmic reticulum (Bornemann et al., 1995; Brewer and Corley, 1996) hinders the accessibility of Asn563 glycans to the Golgi enzymes, preventing their processing (Cals et al., 1996) . It is also possible that pentamers and hexamers undergo a differential glycan processing (Monica et al., 1995) .
The processing of µ-chain N-glycans by Golgi enzymes results in the assembly of heterogeneous complex-type species, which include tri-, di-antennary and hybrid type glycans with a different extent of sialylation (Anderson and Grimes, 1982; Anderson et al., 1983 Anderson et al., , 1985 Monica et al., 1995) . So far, only α2,6-linked sialic acid has been reported to occur in human and mouse IgM. However, N-glycolylneuraminic acid is predominant on N-acetylneuraminic acid in mouse IgM but not in human (Anderson et al., 1985) . Another feature of murine IgM is the occurrence of the Galα1,3Gal-epitope at the non-reducing-terminal end of complex-type glycans (Anderson et al., 1985; Monica et al., 1995) . Such a sequence is produced by the enzyme α1,3Gal-transferase (α1,3GalT), which transfers α-linked galactose to the 3-O position of galactosyl residue in the Galβ1,4GlcNAc-unit of antennary glycans. The sialylation at both the 3-O or 6-O positions of galactosyl residues abrogates in vitro the action of α1,3Gal-T (Blanken and Van den Eijnden, 1985) . This enzyme is not expressed in humans, apes, and Old-World monkeys (Galili et al., 1987) due to frameshift and nonsense mutations within the α1,3Gal-T ortholog gene (Joziasse et al., 1989; Larsen et al., 1990) .
Here we investigated the terminal glycosylation of a set of 4-hydroxy-3-nitrophenylacetyl (NP)-specific murine IgM variants secreted by B1.8 hybridoma cells and by different transfectants derived from the J558L line, a spontaneous heavy chain-lostvariant of mouse myeloma cells, which has been extensively used as recipient for transfections (Neuberger, 1983; Oi et al., 1983; Sitia et al., 1990; Lund et al., 1993; Cals et al., 1996) . We found that J558L cells are deficient in the α2,6-sialyltransferase [α2,6ST(N)] responsible for the sialylation of N-glycans. We have taken advantage of this observation to establish whether the defect in the sialylation resulted in an increased addition of α1,3Gal residues to N-glycans of µ-and J-chains. We analyzed also the expression of Galα1,3Gal epitope in IgM from J558L cells that secrete IgM in different oligomeric forms (Sitia et al., 1990; Cals et al., 1996) . Our results show that sialylation competes in vivo with the expression of the Galα1,3Gal epitope and alters the complement-dependent cytolytic properties of IgM.
Results

Different processing of the µ-and J-chain glycans in B1.8 and J[µs] cells
J[µs] is a stable J558L transfectant expressing B1.8-derived secretory µ chains (µs). These chains assemble with the endogenous J558L λ light chains to form NP-specific IgM that are secreted as polymers (Sitia et al., 1990) . As shown in Figure  1A , µ-and J-chains secreted by J[µs] cells exhibited an electrophoretic mobility faster than those from B1.8 cells. Treatment with PNGase F abolished the differences in the electrophoretic mobility for both µ-and J-chains, indicating that N-glycosylation was responsible for the host-cell dependent migration patterns ( Figure 1B ). To ascertain whether these were due to a dissimilar efficiency of conversion from high-mannose to antennary glycans, IgM from B1.8 and J[µs] cells were treated with endo-β-N-acetylglucosaminidase H (Endo-H) an enzyme that cleaves selectively high mannose glycans. The similar susceptibility of µ chains and the resistance of J chains to Endo-H excluded significant differences in the processing of high-mannose glycans (Figure 1 B) .
SDS-PAGE analysis of µ-chains from cell lysates provided additional evidences that IgM from the two cells lines are differentially processed. The µ-chains from B1.8 lysates migrated as a doublet, the mobility of the upper band being similar to that found in secreted IgM. On the contrary, in the lysates of J[µs] cells a single band was observed with a mobility very close to that of secreted µ chains ( Figure 1C ). Pulse labeling experiments with radioactive galactose (Sitia et al., 1990; M.M.Cals and R.Sitia, unpublished observations) suggest that the faster migrating band present in B1.8 cells is an intracellular precursor not yet processed by Golgi enzyme, whereas the slower band corresponds to galactosylated µ-chains that are being transported as polymers through the late Golgi cisternae. In J[µs] cells, therefore, the mobility shift caused by the Golgi processing of N-glycans is modest compared to B1.8.
Differences in the sialylation of IgM secreted by B1.8 and J[µs]
The presence of sialic acid generally results in a significant reduction of the electrophoretic mobility of glycoproteins. Treatment with neuraminidase altered significantly the migration of µ-chains from B1.8 cells, but not from J[µs] (Figure 2) , strongly suggesting the absence of sialic acid in IgM produced by the latter cells. To substantiate this, µ-and J-chains were probed with Sambucus niger agglutinin (SNA), a lectin recognizing α2,6-linked sialic acid (Shibuya et al., 1987 ). An evident SNA-staining was observed in µ-chains from B1.8 cells only. As expected, SNA reactivity disappeared after neuraminidase treatment (Figure 2 ). The J-chain band from B1.8 cells was not visualized by SNA. Since the lectin bind preferentially multivalent ligands, this likely depends on the occurrence of a single glycan in J-chains. Indeed, an appreciable mobility shift is observed in B1.8-derived J chains upon neuraminidase digestion (Figure 2 ) confirming that also this small polypeptide undergoes sialylation.
The cell-surface reactivity to FITC-conjugated-SNA was investigated by cytofluorimetric analysis. The vast majority of B1.8 cells appeared to be strongly positive, whereas most J[µs] cells were negative (Figure 3 ). These results indicate that the J[µs] cells do not expose to the cell-surface α2,6 sialylated glycoconjugates. Thus, the absence of sialylation is not confined to IgM. IgM purified from the medium were treated with Endo-H or PNGase-F (see Materials and methods for details). The glycosidase insensitive bands migrating just above J chains likely correspond to the abundant λ-chains present in the supernatants (Kaji and Parkhouse, 1974) . (C) IgM were immunoprecipitated from cell lysates and µ-chains revealed as above. Arrows indicate the mobility of µ-chains from the corresponding IgM.
Patterns of terminal glycosyltransferases in B1.8 and J[µs] cells
The absence of α2,6sialylated glycans in IgM produced by J[µs] cells could be explained by a deficient expression of α2,6ST(N) and/or of other glycosyltransferases involved in the assembly of the N-acetyllactosamine unit that is the acceptor substrate for the α2,6ST(N). Therefore, the activity of α2,6ST(N) and other glycosyltransferases including that of α1,3GalT was determined in both cells (Table I) . α2,6ST(N) activity was present in B1.8, but undetectable in J[µs] cells. In contrast, β1,4GalT, responsible for the termination of N-acetyllactosamine unit, and α1,3GalT were similarly expressed in both cells. These results indicate that the deficient α2,6sialylation in J[µs] is dependent on the absence of α2,6ST(N) activity. Glycosyltransferase activities were assayed as described in Materials and methods. Means of two or three separate experiments. 
Comparison of α1,3 -galactosylation in IgM from B1.8 and J[µs] cells
Two approaches were followed to ascertain the extent of α1,3-galactosylation in µ-and J-chains: the reactivity to GS-IB4, a lectin recognizing terminal α-linked galactose (Wood et al., 1979) and the sensitivity to coffee bean α-galactosidase. When blots containing IgM resolved under reducing conditions were probed with GS-IB4, only µ-chains from J[µs] showed an evident reactivity ( Figure 4 ). The staining disappeared upon α-galactosidase treatment, confirming that N-glycans were capped by α-linked galactose residues. As in the case of SNA, J-chains were not stained by GS-IB4; however, α-galactosidase digestion produced a small and consistent increase of their mobility. The shift was not evident in µ-chains, likely due to their higher molecular weight. Altogether these results indicate that the absence of α2,6sialylation in J[µs] cells correlates to an increased addition of α1,3galactose residues to µ-and J-chain glycans.
Complement-dependent cytolytic activity and K on values of IgM from B1.8 and J[µs] cells
IgM from J[µs] exhibit a cytolytic activity against NP-kephalyn coated erythrocytes higher than that of IgM from B1.8 ( Figure  5A ). This difference was in part reduced by neuraminidase treatment of B1.8 IgM, confirming that the sialylation affects the hemolytic properties of IgM. In addition the k on values describing the association kinetics with immobilized NP-BSA were higher for J[µs] IgM (8.2 × 10 5 M -1 sec -1 ) than for B1.8 IgM (2.0 × 10 5 M -1 sec -1 ) ( Figure 5B ). Again neuraminidase treatment of B1.8 IgM reduced the gap (3.5 × 10 5 M -1 sec -1 ). Thus, sialylation seems to negatively affect the association rate of IgM. Due to the multivalent binding of IgM to NP-BSA, the dissociation rates could not be determined. In these conditions, the k off values exceed (<10 -5 sec -1 ) the detection limits imposed by the Biacore system.
Correlations between IgM polymerization and µ-chain α1,3-galactosylation.
The accessibility of glycans to glycosyltransferases is a crucial event in the processing of multimeric glycoproteins. Therefore, the expression of Galα1,3Gal epitope was determined in mutant µ-chains which are assembled and secreted either as monomers (µ2L2) or as polymers. Three different mutants were selected: µAla565 lacking the C-terminal glycosylation site, µAla575 lacking the tailpiece Cys575 and the double mutant µAla565Ala575 (Guenzi et al., 1994; Cals et al., 1996) . As previously reported (Cals et al., 1996) Figure 6A ; de Lalla et al., unpublished observations). Since J[µs] and B1.8 cells secreted IgM polymers with a similar mobility, α2,6sialylation does not seem to affect polymerization ( Figure 6A ). As expected, all mutants µ-chains were resistant to neuraminidase and no α2,6ST(N) activity was found in the lysates of J558L transfectants (results not shown).
When mutant IgMs were resolved under reducing conditions and blotted, µAla575 appeared to bind significantly more GS.IB4 than the double mutant, while µAla565 was poorly reactive to the GS.IB4 (Figure 6B,C) . Treatment with α-galactosidase abrogated the lectin-reactivity of all three µ-chains, but only in the case of µAla575 chains was an appreciable mobility shift observed ( Figure 6B ). The electrophoretic migration was not affected by Aspergillus niger β-galactosidase digestion (results not shown). Altogether, these results indicate that µ-chains are more efficiently α1,3-galactosylated in monomeric IgM.
Degree of N-glycans processing in monomeric and polymeric IgM
While polymeric IgM manufactured by J[µs] contain µ-chains that are sensitive to Endo H (see Figure 1B) , monomers secreted by J[Ala575] are resistant (Cals et al., 1996) . To gain more information as to the processing of glycans as a function of oligomerization, pronase-glycopeptides were obtained from [ 3 H] mannose-labeled IgM from J[µAla575] and J[µs], and their chromatographic profiles on ConA-Sepharose columns compared. The affinity of N-glycans for ConA-Sepharose depends on the degree of processing of the oligomannoside core. High-mannose glycans strongly bind to ConA-Sepharose, and they are eluted only at high concentrations of α-methylmannoside. Upon conversion into antennary species, the affinity for ConA-Sepharose decreases as a function of the number of the antennae bound to the trimannosyl core: triantennary and more branched glycans are not retained, while the diantennary species are eluted at a low (5 mM) α-methylmannoside concentration (Baenziger, 1985) . As shown in Figure 7 , the relative proportion of high-mannose glycans is significantly decreased in monomeric IgM, suggesting that the tailpiece glycan is largely converted to complex-type. Consequently, the percentage of glycopeptides with low affinity to ConA-Sepharose (peaks A and B) largely exceeded that recovered in polymeric IgM (71% versus 27%, in terms of radioactivity). Interestingly, only glycopeptides from polymeric IgM was eluted in large proportion (40% in terms of radioactivity) as a retarded peak by 5 mM methylmannoside (peak C). A reduced accomplishment of the N-acetyllactosamine sequence in the diantennary glycans could explain this behavior. Indeed, partially elongated diantennary glycans exhibits a higher affinity for the lectin (Baenziger and Fiete, 1979) .
Discussion
The compartmentalization of glycosyltransferases along the exocytic pathway dictates the assembly of specific glycan sequences, particularly in the case of glycosyltransferases acting toward sugars of the core structure (Fukuda, 1990) . Glycoproteins are often differently processed as the result of the dissimilar expression of glycosyltransferases, an event associated to the differentiation of certain cell lineages (Feizi, 1985) . Other conditions may alter the glycan assembly and processing. For instance, the prolonged permanence of a glycoprotein in a given compartment may favor the action of the enzymes residing in that compartment (Wang et al., 1991) . In addition, certain posttranslational modifications, in particular assembly and/or oligomerization which occur in the early compartments of the secretory pathway, may affect glycan processing by limiting the accessibility of some acceptors to the Golgi enzymes (Kornfeld and Kornfeld, 1985; Dahms and Hart, 1986; Cals et al., 1996) . Finally, the deficient expression of one glycosyltransferase may favor the addition of a specific sugar by another glycosyltransferase which competes for the same acceptor substrate.
Our results indicate that the two latter mechanisms play a relevant role in regulating the terminal glycosylation of murine IgM. We found that the absence of α2,6ST(N) activity leads to an increased addition of α-linked galactose residues to µ-and J-chains, without changes in the expression of α1,3Gal-transferase activity. Thus, a competition reaction between α2,6ST(N) and α1,3GalT occurs in mouse cells secreting IgM, and the fulfillment of complex-type IgM glycans is regulated by the relative expression of the two glycosyltransferases, which in all likelihood reside in the same stack of the Golgi apparatus (Cho and Cummings, 1997) . A competitive reaction between α1,3GalT and the α2,3ST has been documented in Chinese hamster ovary cells upon transfection of the former enzyme (Smith et al., 1990) . Thus, the low amount of Galα1,3Gal-sequences detected by Anderson et al. (1985) in IgM produced by a mouse myeloma could be due to the high expression of α2,6ST(N). In human B-cells, the expression of α2,6ST(N) appears to be developmentally regulated. The loss of HB6, CDw75, and CD76 antigens from the surface when B-lymphocytes mature into plasma cells seems to correlate with reduced α2,6ST(N) activity Munro et al., 1992) . It is worth noting that also a human myeloma cell line has been shown to be deficient in α2,6ST(N) (Gross et al.,1996) . The regulated expression of α2,6ST(N) might be important during lymphocyte development, in view of the crucial role that CD22, the sialoadhesin specific for the α2,6-linked sialic acid, plays in B cell activation (O'Keefe et al., 1996) . That IgM sialylation might have important functional implications was somehow expected in view of the vicinity of the Asn402 glycans to the C1 binding site on IgM. This glycan is thought to be involved in the initiation of the classical complement activation (Wright et al., 1990) . This is supported by the reduced cytolytic activity of IgM secreted by α2,6ST(N) positive B1.8 cells, and by the effects of digestion with neuraminidase. However, the k on values describing the association rate of B1.8-and J[µs]-IgM with the antigen also appear to be negatively affected by the presence of sialic acid. Even the increased binding of neuraminidase-treated B1.8 IgM might account for the partial recovery of cytolytic activity.
Apart from the interest in terms of comparative biology, the expression of α2,6ST(N) in rodents is relevant in that murine cell lines are routinely used for recombinant glycoprotein synthesis and there is evidence that mouse-human heterohybridomas exhibit glycosylation patterns more similar to those typical of murine cells (Tandai et al., 1991; Monica et al., 1995; Jenkins et al., 1996) . The possibility that IgM produced by heterohybridomas acquire the Galα1,3Gal epitope is not inconsequential in respect of their putative use in vivo. Anti-Galα1,3Gal antibodies are present in humans representing as much as 1% of circulating IgG, very likely generated by continuous stimulation by antigens exposed on the surface of gastrointestinal bacteria (Galili et al., 1984) . Different approaches have been developed to overcome this problem, e.g., the downregulation of the α1,3Gal-transferase in the lines utilized for the production of heterohybridomas (see Jenkins et al., 1996 , and references therein). Our results support the notion that the overexpression of α2,6ST(N) may be an alternative way to hinder the assembly of Galα1,3Gal epitope.
The data gathered in this study show also that the Galα1,3Gal epitope is expressed at a very high degree when µ-chains are secreted prevalently as µ2L2 monomers. The subterminal µ chain Cys575 mediates the covalent oligomerization and the quality control of unpolymerized subunits, as well as the insertion of J-chain into IgM pentamers (Davis et al., 1989; Sitia et al., 1990; Randall et al., 1992; Fra et al., 1993) . For these reasons, J[µAla575] cells secrete prevalently monomers. A different glycan processing in mutant µAla575 chains was suggested by Cals et al. (1996) on the basis of a slower mobility in SDS-PAGE and a larger incorporation of [ 14 C]galactose relative to wild-type µ-chains. The latter observation is consistent with the finding that α-galactosidase digestion significantly increases the electrophoretic migration only in µAla575 chain ( Figure 6B ). This result indicates the large degree of α1,3galactosylation when IgM transit as monomers along the Golgi apparatus. We found also that the lack of IgM polymerization favors the conversion of high-mannose glycans into antennary species, probably elongated up to the Galβ1,4GlcNAc sequence. To what extent this elongation contributes to the assembly of the Galα1,3Gal epitope in monomeric IgM cannot be quantitated. On the other hand, the better accessibility of glycans in monomeric IgM to all enzymes (glycosidases and glycosyltransferases) involved in the full processing of carbohydrate side-chains is very likely responsible for both events.
In physiological conditions, the serum contains mainly polymeric IgM, but in some pathological conditions, such as chronic hepatopathies, lupus erythematosus, and rheumatoid arthritis, circulating IgM monomers are-for unclear reasonssignificantly increased (Harisdangkul et al., 1975; Fakunle et al., 1979) . It is possible that the larger elongation of glycans in IgM monomers (corresponding in humans to an increased sialylation) reduces the clearance by the asialoglycoprotein receptor. A longer half-life may represent an additional way for the accumulation of circulating monomeric IgM in certain pathological conditions.
Materials and methods
Cells
B1.8, a mouse hybridoma producing IgM specific for the hapten 4-hydroxy-3-nitroacetyl (NP) (Reth et al., 1978) , was maintained in RPMI 1640 supplemented with 5% fetal calf serum (FCS), 2 mM glutamine, 1 mM Na-pyruvate, penicillin and streptomycin 5 U/ml. Stable J558L transfectants expressing wild type (J[µs]) or differently mutated µ chains (J[µAla575], J[µAla565], or J[µAla565Ala575] ) were originated as described previously (Sitia et al., 1990; Guenzi et al., 1994; Cals et al., 1996) and maintained in DMEM supplemented with 5% FCS, 5 µg/ml mycophenolic acid, 13.6 µg/ml hypoxanthine, 0.25 mg/ml xanthine, 2 mM glutamine, 1 mM Na-pyruvate, penicillin, and streptomycin.
Preparation of IgM and Western blotting
Cell supernatants were immunoprecipitated by NP-Sepharose beads. After washing three times in 150 mM NaCl, 50 mM Tris-HCl pH 7.5, 5 mM EDTA, 0.5% NP-40 and once in 5mM Tris-HCl pH 7.5, the immunoprecipitates were eluted at 95_C for 2 min in Laemmli buffer and analyzed by SDS-PAGE. Proteins were transferred electrophoretically onto nitrocellulose membranes (Hybond-ECL Western, Amersham). Blots were blocked in 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% Tween-20 with 2.5% nonfat dry milk. Blots were decorated with class specific antibodies conjugated to horseradish peroxidase (HRP) (Southern Biotechnology Associates Inc., USA) and developed with the ECL detection system as recommended by the supplier (Amersham International). When the reactivity to the lectin was analyzed, blots were treated with 2.5% blocking reagent (DIG glycan differentiation kit, Boehringer, Mannheim, Germany), then incubated with digoxigenin labeled SNA followed by anti digoxigenin-HRP or with biotinylated Griffonia simplicifolia (GS-IB4), purchased from Sigma, followed by streptavidin-HRP. In some experiments J-chains were detected using a rabbit anti mouse J-chain antiserum (a kind gift of Dr. R. M. E. Parkhouse) followed by HRP-conjugated goat anti rabbit.
Treatment of IgM with endoglycosidase H (Endo-H) and PNGase-F
IgM were prepared from supernatants by ammonium sulfate precipitation (50% w/v). After extensive dialysis, aliquots were digested with Endo-H or with PNGase F (Boehringer, Mannheim) in 200 mM Na-Acetate pH 5.5, 0.02% SDS, 0.8 mM phenylmethylsulfonyl-fluoride and 200 mM Na-Phosphate pH 7.5, 50 mM EDTA, 4% Triton X-100, 2% SDS, 2% -mercaptoethanol, respectively. After 18 h at 37_C the samples were resolved by SDS-PAGE under reducing conditions and blotted onto nitrocellulose membranes.
Treatment of IgM with neuraminidase or α-galactosidase
IgM secreted by various cells were affinity purified with NP-Sepharose and washed as described above. Aliquots of the beads were resuspended in 50 mM Na-acetate buffer pH5.5, 1 mM CaCl 2 , and incubated at 37_C for 18 h with or without Vibrio cholerae neuraminidase from Behring (2 mU). For digestion with green coffee bean-galactosidase (Sigma), beads were resus-pended in 10 mM HEPES pH 6.5, 150 mM NaCl, 5 mM CaCl 2 . The enzyme was added at 0, 12, and 24 h (total amount 10 mU), and the incubation was at 37_C for 36 h. The reactions were stopped by boiling samples for 3 min. As controls, enzymes boiled for 3 min before addition to samples were used. Samples were then resolved on SDS-PAGE and blotted as described above.
Radioactive labeling and fractionation of [ 3 H]mannose labeled pronase glycopeptides from IgM .
Approximately 10 7 J[µs] or J[µAla575] cells were labeled with 200 µCi [ 3 H]mannose (specific activity 25 mCi/mmol from New England Nuclear) for 16 h and secreted IgM were affinity purified with NP-Sepharose as described above. Beads were then incubated with Pronase for 16 h at 60_C and released glycopeptides were gel-filtrated on Bio-Gel P-4 (Serafini- Cessi et al., 1985) . Fractions containing glycopeptides were pooled, lyophilized, and chromatographed on a ConA-Sepharose column as described previously (Serafini-Cessi et al., 1989) .
Immunofluorescence
B1.8 and J[µs] cells (5 ×10 5 ) were washed three times with 0.02 M Na-phosphate buffer, pH 7.4, and 0.14 M NaCl containing 0.02% NaN 3 (PBS+NaN 3 ). The cells were then incubated on ice for 30 min with 50 µl of FITC-SNA. After three washes with PBS+NaN 3 the fluorescence was analyzed using a FACScan flow cytometer (Becton Dickinson).
Glycosyltransferase assays
B1.8 and J[µs] cells were washed three times with cold PBS and homogenized in ice cold water and the homogenate was used as a source of enzymes.
α2,6-and α2,3-sialyltransferase. The standard assay mixture contained 100 mM sodium cacodylate buffer, pH 6.5, 5 mM MnCl 2 , 80 µM CMP-[ 14 C]NeuAc (37 d.p.m./pmol) 0.5% Triton X-100 and N-acetyllactosamine (0.65 µmol) as acceptors. Usually 75-100 µg of homogenate-proteins were added as enzyme source in a final volume of 50 µl. Samples were incubated at 26_C for 2 h and the reaction was stopped by 0.5 ml of cold water. [ 14 C]NeuAc-α2,6Galβ1,4GlcNAc and the corresponding αNeuAc2,3-isomer were separated by HPLC on a Merck Lichrosorb-NH 2 (12.5 × 0.4 cm) column as described by Bergh et al. (1981) .
β1,4Gal-transferase. The assay mixture contained 0.1 M sodium cacodylate buffer, pH 6.5, 5 mM MnCl 2 , 0.5 mM UDP-[ 14 C]Gal (5.6 d.p.m./pmol), 0.5% Triton X-100, ATP 64 mM, and 0.65 µmol of GlcNAc as an acceptor in a total volume of 50 µl containing 70-80 µg of protein homogenate. After 2 h at 37_C the reaction was stopped with 1 ml of cold water and the mixture was passed through a column (1 × 3 cm) of Dowex 1×8 (Cl -) equilibrated with water. The column was eluted with 3 ml of water. The eluted sample was lyophilized and analyzed by HPLC as described previously (Malagolini et al., 1994) . The fractions with the retention time of N-acetyllactosamine (Galβ1,4GlcNAc) were counted for radioactivity.
α1,3Gal-transferase. The assay mixture and the subsequent procedure was the same described for β1,4Gal-transferase except that N-acetyllactosamine (0.65 µmol) was used as an acceptor. The HPLC fractions counted for radioactivity were, in this case, those with the retention time of a neutral trisaccharide (β1,4Gal-NAcGalβ1,4GlcNAc) isolated as described previously (Malagolini et al., 1994) .
Complement-dependent hemolysis assays
Red blood cells (RBC) were obtained from BALB/c mice according to the HSR Institutional Animal Care guidelines, pelleted and stored in Alsever's solution at 4_C. Before use, the RBC were washed three times and then incubated for 2 h at 37_C with 600 µg/ml of NP-cap-kephalyn (a kind gift of M. S. Neuberger, Cambridge, UK) in TC199 medium supplemented with 1 mM MgCl 2 , 1 mM CaCl 2 . RBC were then washed three times in PBS and diluted 1:50 in TC199 medium supplemented with 1 mM MgCl 2 , 1 mM CaCl 2 . A 25 µl aliquot of NP-coated RBC suspension were mixed with 25 µl of IgM at different concentrations (from 20 to 1200 ng/ml). After 10 min at 37_C, 5 µl of guinea pig complement (Sigma Chemical Company, St. Louis) were added. After an additional 10 min at 37_C, hemolysis was quantitated by spectrophotometric analyses (absorbance at 405 nm) of the supernatants diluted in 100 µl of PBS.
BIAcore analysis
Affinity measurements were performed by the BIAcore equipment (Pharmacia-Biosensor AB, Sweden) at a flow rate of 5 µl/min in running buffer (10 mM Hepes pH 7.4, 3.4 mM EDTA, 0.05% BIAcore Surfactant P20, 0.15 M NaCl) with injection volumes of 20 µl (Jhonsson et al., 1991; Chaiken et al., 1992) . The antigen (NP-BSA, 6:1 molar ratio) was immobilized on BIAcore Sensorchips by the "Surface Thiol Method" following the manufacturer's recommendations. Sensorchips were regenerated with 6 mM NaOH, pH 12, at a flow rate of 20 µl/min. IgM polymers were dialyzed against running buffer and diluted in the same buffer to a final concentration of 43, 86, 172 ng/µl in the case of B1.8 IgM and 7, 14, 28 ng/µl for J[µs] IgM. The k on values were calculated by the kinetic evaluation software program (Pharmacia-Biosensor).
